Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. |
2023-01-30 |
Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. |
2023-01-25 |
Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director". |
2023-01-24 |
AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. |
2023-01-24 |
Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm. |
2023-01-16 |
TATAA Biocenter AB. (1/11/23). "Press Release: TATAA Biocenter Partners with Universal Sequencing Technology Corporation to Offer “Linked Long Read” Sequencing Services". |
2023-01-11 |
Oncopeptides AB. (1/11/23). "Press Release: Oncopeptides Appoints Holger Lembrer as Chief Financial Officer". Stockholm. |
2023-01-11 |
Evosep ApS. (1/9/23). "Press Release: Evosep Receives Strategic Investment from Novo Holdings A/S to Accelerate Its Effort on Clinical Proteomics". Odense. |
2023-01-09 |
Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. |
2023-01-09 |
Agilent Technologies Inc.. (1/6/23). "Press Release: Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications". Santa Clara, CA & Marlborough, MA. |
2023-01-06 |
Oncopeptides AB. (1/4/23). "Press Release: Monica Shaw Appointed CEO of Oncopeptides – Jakob Lindberg Assumes Position as Chief Scientific Officer". Stockholm. |
2023-01-04 |
Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO". |
2023-01-02 |
Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. |
2022-12-23 |
European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". |
2022-12-23 |
ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. |
2022-12-19 |
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. |
2022-12-12 |
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm. |
2022-12-07 |
MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". |
2022-11-29 |
Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. |
2022-11-24 |
Novo Nordisk A/S. (11/22/22). "Press Release: Novo Nordisk Invests DKK 5.4 bn Danish Kroner in Expansion of Clinical Manufacturing Facilities in Bagsværd, Denmark". Bagsværd. |
2022-11-22 |
Accession Therapeutics. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". |
2022-11-18 |
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. |
2022-11-11 |
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". |
2022-11-08 |
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. |
2022-11-07 |
Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. |
2022-10-31 |
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. |
2022-10-24 |
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. |
2022-10-20 |
Hemispherian AS. (10/19/22). "Press Release: Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program". Oslo. |
2022-10-19 |
Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. |
2022-10-17 |
Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. |
2022-10-11 |
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. |
2022-10-10 |
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. |
2022-10-07 |
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. |
2022-09-30 |
Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. |
2022-09-29 |
Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". |
2022-09-21 |
Onego Bio Ltd.. (9/20/22). "Press Release: Perfect Day Deepens Investment in Enterprise Biology Business with New Brand Identity, nth Bio, and Announces Partnership with Onego Bio". Salt Lake City, UT. |
2022-09-20 |
Novo Nordisk A/S. (9/12/22). "Press Release: Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence". Bagsværd & Redmond, WA. |
2022-09-12 |
Pretzel Therapeutics. (9/12/22). "Press Release: Pretzel Therapeutics Launches with $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies". Waltham, MA. |
2022-09-12 |
Onego Bio Ltd.. (9/7/22). "Press Release: Onego Bio Secures EUR 4.5M Additional Funding to Accelerate Research and Development". Helsinki. |
2022-09-07 |
EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology". |
2022-09-06 |
Biohit Oyj. (9/2/22). "Press Release: Change of CEO at Biohit Oyj". |
2022-09-02 |
Novo Nordisk A/S. (9/1/22). "Press Release: Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders". Bagsværd & Watertown, MA. |
2022-09-01 |
eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. |
2022-08-23 |
SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". |
2022-08-22 |
Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
BioInnovation Institute (BII). (8/22/22). "Press Release: BII Supports Three International Start-ups Developing Pioneering Science in the Therapeutics and Health Tech Space". |
2022-08-22 |
Carbios S.A.. (8/9/22). "Press Release: WhiteCycle – a European Consortium to Recycle Plastic Waste". Clermont-Ferrand. |
2022-08-09 |
Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". |
2022-08-08 |
Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen. |
2022-08-08 |
BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. |
2022-08-05 |
Active Biotech AB. (8/4/22). "Press Release: Active Biotech Announces a Rights Issue of approximately SEK 55 Million [Not for release in US, AU, CA, JP, et al.]". |
2022-08-04 |
Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth. |
2022-07-28 |
Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków. |
2022-07-26 |
Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. |
2022-07-20 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". |
2022-07-18 |
Lidds AB. (7/15/22). "Press Release: Lidds AB (publ) Announces the Appointment of Anders Månsson as CEO". Uppsala. |
2022-07-15 |
BioInvent International AB. (7/12/22). "Press Release: BioInvent Has Successfully Carried Out a Directed Share Issue of approximately SEK 300 Million (approximately USD 28.3 Million) [ Not for US, AU, et al. ]". Lund. |
2022-07-12 |
Navinci Diagnostics AB. (7/12/22). "Press Release: Navinci Diagnostics AB Announces Closing of SEK 90M Series A Financing, Led by Segulah Medical Acceleration with Support from Existing Shareholders". |
2022-07-12 |
Biosaxony. (7/12/22). "Pressemitteilung: Medical Forge Leipzig lässt die Funken fliegen". |
2022-07-12 |
ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. |
2022-07-08 |
ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. |
2022-07-07 |
Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin. |
2022-07-05 |
Nordic Nanovector ASA. (7/5/22). "Press Release: Nordic Nanovector to Discontinue PARADIGME, Its Phase 2b Trial with Betalutin in 3L R and R Follicular Lymphoma". Oslo. |
2022-07-05 |
FMC Corporation. (6/29/22). "Press Release: FMC Corporation Significantly Expands Biologicals Platform with Agreement to Acquire BioPhero". Philadeliphia, PA. |
2022-06-29 |
Centogene N.V.. (6/27/22). "Press Release: Centogene Announces Appointment of Miguel Coego Rios as Chief Financial Officer". Cambridge, MA, Rostock & Berlin. |
2022-06-27 |
EQT AB. (6/22/22). "Press Release: EQT Private Equity to Acquire SPT Labtech, a Fast-growing Laboratory Automation Player Focused on Low-volume Liquid Handling Technology for GBP 650 Million from Battery Ventures". Stockholm. |
2022-06-22 |
FMC Corporation. (6/22/22). "Press Release: FMC Corporation Unveils New Plant Health Business Brand Identity, 'Biologicals by FMC,' Reflecting Company's Commitment to Biological Crop Protection". Philadeliphia, PA. |
2022-06-22 |
CH-Bioforce Oy. (6/21/22). "Press Release: CH-Bioforce to Receive up to €15 Million in Funding from European Innovation Council". |
2022-06-21 |
ProtonDx Ltd.. (6/21/22). "Press Release: ProtonDx New Rapid Multi-Viral Pathogen Detection System Receives CE-IVD Mark". London. |
2022-06-21 |
Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. |
2022-06-21 |
Elypta AB. (6/20/22). "Press Release: Elypta Raises $21 Million Series A to Develop Metabolism-based Multi-cancer Early Detection Test". Stockholm. |
2022-06-20 |
ImCheck Therapeutics S.A.S.. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immuno |
2022-06-13 |
Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. |
2022-06-09 |
Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. |
2022-06-08 |
Synklino ApS. (6/8/22). "Press Release: Synklino Completes Series A Raise of EUR 29.8 Million to Advance Clinical Trials of Its Drug Candidate for the Treatment of Cytomegalovirus (CMV)". Copenhagen. |
2022-06-08 |
BioInnovation Institute (BII). (6/2/22). "Press Release: High-quality Project from EMBL Is the First to Enter the Bio Studio Program". |
2022-06-02 |
Scienion GmbH. (6/1/22). "Press Release: Scienion Appoints Frauke Hein as CEO". Berlin. |
2022-06-01 |
Colorifix Ltd.. (5/27/22). "Press Release: £18m Series B Round Raised to Accelerate the Adoption of Our Sustainable Textile Dyeing Solutions". Cambridge. |
2022-05-27 |
UK Government (Office for Life Sciences). (5/27/22). "Press Release: UK Commits to Life Sciences Cooperation with Sweden". |
2022-05-27 |
Pancryos ApS. (5/24/22). "Press Release: Pancryos Announces Exclusive Global License Agreement for First in Class Macroencapsulation Device". Copenhagen. |
2022-05-24 |
Cinclus Pharma Holding AB. (5/20/22). "Press Release: Cinclus Pharma Has Carried Out a Successful Private Placement of approximately SEK 240m". Stockholm. |
2022-05-20 |
Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. |
2022-05-19 |
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. |
2022-05-17 |
Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. |
2022-05-16 |
Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. |
2022-05-16 |
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Proposes Expansion of Supervisory Board. Dr. Eva Pisa Proposed as a New Member to the Supervisory Board". Venlo. |
2022-05-11 |
Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
Novo Nordisk A/S. (5/10/22). "Press Release: Novo Nordisk and Flagship Pioneering Announce a Strategic Collaboration to Create a Portfolio of Transformational Medicines". Bagsværd & Cambridge, MA. |
2022-05-10 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (5/9/22). "Press Release: SHS Strengthens Finance Team. Lukas Maucher Joins Tübingen-based Private Equity Investor as CFO". |
2022-05-09 |
Bico Group AB. (5/6/22). "Press Release: Bico Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored products". |
2022-05-06 |
Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. |
2022-05-05 |
Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel. |
2022-05-03 |
Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. |
2022-05-03 |
BioPhero ApS. (5/3/22). "Press Release: BioPhero Closes First Sale". |
2022-05-03 |
Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA. |
2022-05-02 |